THNR Short Volume
Amplify Weight Loss Drug & Treatment ETF (THNR) operates in the Financial Services sector, specifically the Asset Management industry, with a market capitalization near $3.2M, listed on AMEX, carrying a beta of 0.41 to the broader market. THNR provides access to global companies expected to economically benefit from weight loss drug development. public since 2024-05-21.
Short volume measures the number of shares sold short on a given day as reported by FINRA. Tracking short volume relative to total volume helps identify unusual bearish sentiment or short-squeeze potential.
- Latest Date
- 2026-06-01
- Short Volume
- 3
- Total Volume
- 64
- Short %
- 4.69%
- 30-Day Avg Short %
- 42.06%
Showing 30 days of FINRA short volume data for Amplify Weight Loss Drug & Treatment ETF.
Learn how short volume is reported and how to read the data →
Frequently asked THNR short volume questions
- What is the daily THNR short volume?
- As of Jun 1, 2026, Amplify Weight Loss Drug & Treatment ETF (THNR) short volume is 3 shares against 64 total reported volume, or 4.69% short-side. Short volume measures shares sold short during the day; it is flow, not inventory.
- How is THNR short volume reported?
- FINRA publishes the Daily Short Sale Volume File for trades reported to FINRA TRFs and the FINRA/Nasdaq ADF on a T+1 basis. The headline figure is the count of shares that printed at the short-sale or short-exempt tick across all reporting venues for the symbol; each exchange separately publishes its own daily short-sale data file.
- What does THNR short volume tell options traders?
- Daily short-sale flow is one input that helps disambiguate dealer-hedging activity from directional bear flow when the chain shows fresh customer call inventory. It is not a clean MM-only proxy: the headline number mixes directional shorting, options-MM delta-hedging, ETF-creation arbitrage, and convertible-arb hedging. Cross-check against gamma-exposure and OI changes for a cleaner read.